Onconetix Financial Statements From 2010 to 2026

Onconetix Balance Sheet		Trends
Current Value Last Year Historical Average  10 Year Trend Total Assets 28.6 M 32.4 M 16 M Slightly volatile Other Current Liabilities 6.1 M 5.8 M 1.4 M Slightly volatile Total Current Liabilities 22.1 M 21 M 5 M Slightly volatile Property Plant And Equipment Net 220.2 K 209.7 K 54.8 K Slightly volatile Accounts Payable 4.6 M 4.4 M 1.2 M Slightly volatile Cash 552.8 K 581.9 K 5.8 M Pretty Stable Non Current Assets Total 20 M 31.3 M 9.5 M Slightly volatile Other Assets 0.8 0.9 0.9824 Slightly volatile Cash And Short Term Investments 552.8 K 581.9 K 5.8 M Pretty Stable Net Receivables 89.4 K 110.8 K 44.9 K Slightly volatile Common Stock Shares Outstanding 39 K 37.1 K 9.2 K Slightly volatile Liabilities And Stockholders Equity 28.6 M 32.4 M 16 M Slightly volatile Other Current Assets 156.6 K 164.9 K 172.9 K Slightly volatile Other Stockholder Equity 153.3 M 146 M 35.3 M Slightly volatile Total Liabilities 20.2 M 21.4 M 9 M Slightly volatile Total Current Assets 1 M 1.1 M 6.1 M Very volatile Common Stock 142 136 41.3635 Slightly volatile Net Invested Capital 11.1 M 20.6 M 7.6 M Slightly volatile Property Plant And Equipment Gross 220.2 K 209.7 K 60 K Slightly volatile Capital Stock 1.3 M 1.2 M 211 K Slightly volatile Short and Long Term Debt Total 7.7 M 8.5 M 9.7 M Slightly volatile Long Term Debt 95.1 K 107 K 116.8 K Slightly volatile Short and Long Term Debt 7.6 M 8.4 M 9.4 M Slightly volatile Non Current Liabilities Other 691.2 K 777.6 K 848.8 K Slightly volatile Short Term Debt 7.7 M 8.5 M 9.5 M Slightly volatile Intangible Assets 20.3 M 22.9 M 25 M Slightly volatile
Onconetix Income Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Depreciation And Amortization 883.1 K 841 K 148.2 K Slightly volatile Other Operating Expenses 71.3 M 67.9 M 15.4 M Slightly volatile Research Development 168.6 K 177.5 K 531.3 K Slightly volatile Cost Of Revenue 1.8 M 1.7 M 361.1 K Slightly volatile Total Operating Expenses 69.5 M 66.2 M 15 M Slightly volatile Selling General Administrative 8.5 M 12.9 M 4.2 M Slightly volatile Reconciled Depreciation 883.1 K 841 K 149.7 K Slightly volatile Selling And Marketing Expenses 1.6 M 1.8 M 1.9 M Slightly volatile
Onconetix Cash Flow Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Stock Based Compensation 588.7 K 504.5 K 254.9 K Slightly volatile Depreciation 883.1 K 841 K 148.2 K Slightly volatile Capital Expenditures 20.4 K 32.7 K 12 K Slightly volatile End Period Cash Flow 552.8 K 581.9 K 5.8 M Pretty Stable Begin Period Cash Flow 9.4 M 5.2 M 6.9 M Pretty Stable Dividends Paid 165.1 K 185.8 K 202.8 K Slightly volatile
Financial Ratios		Trends
Current Value Last Year Historical Average  10 Year Trend Price To Sales Ratio 0.75 0.79 47.8473 Slightly volatile Dividend Yield 0.096 0.11 0.1174 Slightly volatile Days Sales Outstanding 15.21 16.02 772 Slightly volatile Book Value Per Share 325 342 1.6 K Pretty Stable Average Payables 983.7 K 936.9 K 344 K Slightly volatile Stock Based Compensation To Revenue 0.19 0.2 4.6781 Slightly volatile Capex To Depreciation 0.0425 0.0448 5.0323 Slightly volatile EV To Sales 4.56 4.8 124 Slightly volatile Inventory Turnover 10.47 20.63 5.86 Slightly volatile Days Of Inventory On Hand 17.39 18.31 95.3333 Slightly volatile Payables Turnover 0.37 0.35 0.1001 Slightly volatile Sales General And Administrative To Revenue 4.86 5.12 209 Slightly volatile Average Inventory 171.3 K 192.7 K 210.3 K Slightly volatile Research And Ddevelopement To Revenue 0.0668 0.0703 27.4707 Slightly volatile Capex To Revenue 0.0123 0.013 0.7775 Slightly volatile Cash Per Share 21.87 23.02 1.7 K Pretty Stable Days Payables Outstanding 1 K 1.1 K 15 K Very volatile Income Quality 0.2 0.21 0.7834 Slightly volatile Intangibles To Total Assets 0.75 0.86 0.9142 Slightly volatile Current Ratio 0.0568 0.0597 51.5158 Slightly volatile Receivables Turnover 24.77 23.59 4.708 Slightly volatile Capex Per Share 0.75 0.79 2.0012 Pretty Stable Average Receivables 68.2 K 110.7 K 51.7 K Slightly volatile Revenue Per Share 35.9 70.33 20.4139 Slightly volatile Interest Debt Per Share 367 386 1.8 K Slightly volatile Debt To Assets 0.18 0.3 0.141 Slightly volatile Operating Cycle 32.61 34.33 868 Slightly volatile Days Of Payables Outstanding 1 K 1.1 K 15 K Very volatile Ebt Per Ebit 0.8 0.95 0.9506 Pretty Stable Effective Tax Rate 0.0165 0.0157 0.0032 Slightly volatile Total Debt To Capitalization 0.54 0.57 1.9949 Slightly volatile Quick Ratio 0.0529 0.0557 51.5139 Slightly volatile Net Income Per E B T 1.09 1.13 1.0116 Slightly volatile Cash Ratio 0.0386 0.0406 51.1484 Slightly volatile Days Of Inventory Outstanding 17.39 18.31 95.3333 Slightly volatile Days Of Sales Outstanding 15.21 16.02 772 Slightly volatile Free Cash Flow Operating Cash Flow Ratio 1.1 1.15 1.0188 Slightly volatile Fixed Asset Turnover 13.08 12.46 2.5469 Slightly volatile Debt Ratio 0.18 0.3 0.141 Slightly volatile Price Sales Ratio 0.75 0.79 47.8473 Slightly volatile Asset Turnover 0.0846 0.0806 0.0155 Slightly volatile
Onconetix Valuation Data		Trends
Current Value Last Year Historical Average  10 Year Trend Market Cap 2.7 M 3 M 3.3 M Slightly volatile Enterprise Value 7 M 7.8 M 8.6 M Slightly volatile

Onconetix Fundamental Market Drivers

Onconetix Upcoming Events

About Onconetix Financial Statements

Pair Trading with Onconetix

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Onconetix position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Onconetix will appreciate offsetting losses from the drop in the long position's value.When determining whether Onconetix offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Onconetix's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Onconetix Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Onconetix Stock:

How To Invest In Onconetix Details

Is Onconetix Stock a good investment? Details

What is Onconetix's Net Worth? Details

Largest Biotechnology Companies View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies View

Altman Z Score Details

Piotroski F Score Details

Beneish M Score Details

Financial Analysis Details

Buy or Sell Advice Details